Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating activities
Net loss	$ (8,537,952)	$ (13,154,671)
Adjustments to reconcile net loss to net cash used in operating activities:
Reserve for obsolete inventory	30,000
Forgiveness of paycheck protection loan and accrued interest	(105,130)
Stock-based compensation expense	1,878,954	1,628,558
Change in operating assets and liabilities:
Accounts receivable, net	(271,882)
Prepaid expenses and other assets	157,593	(396,834)
Inventory	20,946	(236,480)
Accounts payable and other current liabilities	(527,859)	243,356
Accrued compensation	(496,915)	173,070
Accrued interest expense	499,301	112,994
Milestone payable	(5,000,000)	5,000,000
Net cash used in operating activities	(12,352,944)	(6,630,007)
Financing activities
Proceeds from issuance of common stock, net	13,070,154
Proceeds from issuance of common stock from ATM, net	313,107	3,595,713
Proceeds from issuance of common stock from employee stock purchase plan		119,416
Proceeds from issuance of common stock from stock options exercises	45,454	215,816
Proceeds from paycheck protection program		104,168
Proceeds from Eversana line of credit		5,000,000
Net cash provided by financing activities	13,428,715	9,035,113
Net increase in cash and cash equivalents	1,075,771	2,405,106
Cash and cash equivalents at beginning of period	8,068,939	5,663,833
Cash and cash equivalents at end of period	9,144,710	8,068,939
Non-cash financing activities
Forgiveness of paycheck protection loan and accrued interest	$ 105,130